Valuation: Agilent Technologies, Inc.

Market Cap 37.69B 33.15B 30.8B 28.33B 53.12B 3,650B 54.07B 368B 144B 1,780B 142B 138B 6,177B P/E 2026 *
26x
P/E 2027 * 22.7x
Enterprise Value 38.5B 33.86B 31.46B 28.93B 54.26B 3,728B 55.23B 376B 147B 1,819B 145B 141B 6,309B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.72x
Free-Float
99.81%
Yield 2026 *
0.77%
Yield 2027 * 0.82%
08:59am Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers MT
07-21 Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift RE
07-20 HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited CI
07-14 Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma CI
07-14 Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers MT
07-13 Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating MT
07-08 Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis CI
07-06 Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 MT
07-01 Agilent Technologies Launches Xcelligence RTCA Esight AI Module CI
06-26 Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron… Zonebourse
06-25 Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 CI
06-25 Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. CI
06-25 Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group MT
1 day+3.78%
1 week+1.64%
Current month+4.14%
1 month+9.21%
3 months+20.90%
6 months+2.43%
Current year+1.66%
1 week 125
Extreme 125
141.95
1 month 125
Extreme 125
141.95
Current year 108.35
Extreme 108.35
150.1
1 year 108.35
Extreme 108.35
160.27
3 years 96.43
Extreme 96.43
160.27
5 years 96.43
Extreme 96.43
179.57
10 years 42.92
Extreme 42.92
179.57
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-20
Director of Finance/CFO 49 2025-11-16
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Chairman 75 2017-03-15
Director/Board Member 78 2010-12-31
Director/Board Member 72 2015-06-30
Date Insider Type Main position Quantity % Market Cap.
6/26/26 Tax

Executive/Senior Manager

-30 0.0000%
6/3/26 Tax

Chief Executive Officer

-418 0.0001%
6/2/26 Other

Controller/Auditor

8,872 0.0031%
Change 5-day change 1-year change 3-year change Capi.($)
+3.72%+1.64%+15.79%+8.31% 37.69B
+8.69%+5.47%+22.76%+0.24% 196B
+6.52%-6.88%-3.53%-26.00% 126B
-2.65%-17.52%-33.89%+2.56% 120B
+1.08%-2.68%-59.70%-16.76% 63.87B
-1.55%-5.03%+8.46%-8.73% 48.58B
-1.56%-3.21%-26.85%-33.59% 43.93B
+3.32%+1.52%+29.87%+33.78% 36.41B
+1.98%+2.42%+86.26%+3.61% 28.88B
-1.20%-5.92%-30.22%-12.56% 27.83B
Average +1.91%-2.90%+0.89%-4.91% 72.91B
Weighted average by Cap. +3.39%-4.74%-1.81%-6.30%

Financials

2026 *2027 *
Net sales 7.45B 6.55B 6.09B 5.6B 10.5B 721B 10.68B 72.77B 28.39B 352B 27.96B 27.36B 1,221B 7.9B 6.95B 6.46B 5.94B 11.13B 765B 11.33B 77.19B 30.11B 373B 29.66B 29.02B 1,295B
Net income 1.47B 1.29B 1.2B 1.1B 2.07B 142B 2.1B 14.32B 5.59B 69.23B 5.5B 5.38B 240B 1.63B 1.44B 1.34B 1.23B 2.3B 158B 2.34B 15.97B 6.23B 77.21B 6.14B 6B 268B
Net Debt 807M 710M 660M 607M 1.14B 78.18B 1.16B 7.89B 3.08B 38.13B 3.03B 2.97B 132B -401M -353M -328M -301M -565M -38.84B -575M -3.92B -1.53B -18.95B -1.51B -1.47B -65.73B
Logo Agilent Technologies, Inc.
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (71.2%) and services (28.8%). Net sales are distributed geographically as follows: the United States (33.7%), China and Hong Kong (17.6%) and other (48.7%).
Employees
18,000
Date Price Change Volume
26-07-23 US$138.59 +3.84% 1,307,248
26-07-22 US$133.46 +0.45% 2,662,820
26-07-21 US$132.86 +2.00% 2,383,954
26-07-20 US$130.26 -0.91% 2,470,803
26-07-17 US$131.46 -3.41% 4,247,327
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
133.46USD
Average target price
159.32USD
Spread / Average Target
+19.37%

Quarterly revenue - Rate of surprise